When your kidneys don’t work well, they stop making enough erythropoietin, a hormone that tells your bone marrow to make red blood cells. Also known as EPO, this hormone is critical for keeping your blood oxygenated. Without enough of it, you develop anemia in kidney disease, a condition where your body doesn’t have enough healthy red blood cells to carry oxygen. This isn’t just fatigue—it’s a sign your kidneys are struggling, and it can make heart problems, weakness, and shortness of breath worse.
Anemia in kidney disease doesn’t happen alone. It often goes hand-in-hand with iron deficiency, a lack of the mineral your body needs to build hemoglobin. Many people on dialysis lose iron through blood draws or poor absorption. Even if you take iron pills, your body might not use them right if inflammation is high—a common side effect of chronic kidney disease. That’s why doctors check both your iron levels and your kidney function together. Some patients need IV iron instead of pills. Others need injections of synthetic erythropoietin to kickstart red blood cell production. It’s not one-size-fits-all.
What you eat matters, too. A diet low in protein or high in phosphorus can make anemia harder to manage. Medications like ACE inhibitors, which protect your kidneys, can sometimes lower red blood cell counts slightly. And if you’re on dialysis, the treatment itself can remove nutrients your body needs. That’s why tracking your labs—hemoglobin, ferritin, transferrin saturation—isn’t optional. It’s how you know if your treatment is working.
You’ll find real-world advice here on how to handle anemia without overloading your body. Some posts show how to spot early signs before you feel exhausted. Others explain why certain iron supplements work better than others for kidney patients. You’ll see what doctors actually recommend for people on dialysis, and how newer treatments compare to old-school options. No fluff. Just what you need to know to talk to your care team and take control.
Anemia in kidney disease is caused by low erythropoietin and iron problems. Learn how IV iron and ESA therapy work, why targets are now 10-11.5 g/dL, and what newer oral treatments like roxadustat offer.